Cite
MLA Citation
Timothy M Nywening et al.. “Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.” Lancet oncology, vol. 17, no. 5, n.d., pp. 651–662. http://access.bl.uk/ark:/81055/vdc_100032015727.0x00000a